| Generic Name | Domperidone |
|---|---|
| Drug Class | Peripheral Dopamine (D₂) Receptor Antagonist |
| Indications |
|
| Mechanism of Action | Blocks peripheral dopamine (D₂) receptors, enhancing gastric motility and accelerating gastric emptying. Also acts on the chemoreceptor trigger zone outside the blood–brain barrier. |
| Available Forms & Strengths | • Tablet: 10 mg • Oral suspension |
| Dosage | Adults: 10 mg 2–3 times daily (before meals) Children: 0.2–0.4 mg/kg per dose, up to 3 times daily |
| Route | Oral |
| Common Side Effects |
|
| Serious Adverse Effects | QT prolongation, ventricular arrhythmia, sudden cardiac death (rare, dose-related) |
| Contraindications | • Prolonged QT interval • Moderate to severe hepatic impairment • Concomitant QT-prolonging drugs |
| Precautions | • Elderly patients • Cardiac disease • Electrolyte imbalance |
| Drug Interactions | • Macrolide antibiotics • Azole antifungals • Other QT-prolonging drugs |
| Pregnancy & Lactation | Pregnancy: Use if clearly needed Lactation: Generally considered safe (increases prolactin) |
| Storage | Store below 30°C, protect from light |
| References | BNF | BNF for Children | Manufacturer Prescribing Information |